-
Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC
Источник: Buzz FX / 13 ноя 2024 08:56:17 America/New_York
Viridian Therapeutics (NASDAQ:VRDN) Earns Buy Rating from Needham & Company LLC Written by MarketBeat November 13, 2024 Share Link copied to clipboard. Viridian Therapeutics ( NASDAQ:VRDN - Get Free Report ) 's stock had its "buy" rating re
Read more...